Antidote.me
Where patients meet research
HQRemote
Team Size30
Open JobsUnknown
Total Funding$52M
Latest Fundraise5 years ago
Where patients meet research
What they do: Patient-centric technology and services that match patients to clinical trials and support recruitment/engagement
Founded / rebrand: Launched as TrialReach in 2010; rebranded to Antidote (public rebrand announced 2016)
Funding (total disclosed): About $52.1M total disclosed; latest $23.2M round closed June 3, 2021
Offices / markets: Operates in the US and UK; serves patient communities and research customers globally
Clinical trial recruitment and patient engagement for medical research.
2010
Digital health / Clinical trial recruitment
23200000.00
$23.2M round closed June 3, 2021
11000000.00
$11M round announced September 8, 2017
“Led by strategic healthcare and growth investors (LBO France, Merck Global Health Innovation Fund) with participation from Smedvig Capital and Octopus Ventures”